Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Parmax Pharma Limited is an India-based pharmaceutical company that specializes in the manufacturing and marketing of a wide range of pharmaceutical formulations. Established in 1994 and headquartered in Rajkot, Gujarat, the company focuses on delivering high-quality generic medicines across various therapeutic categories, including anti-infectives, analgesics, antipyretics, and nutritional supplements. Their product portfolio includes various dosage forms such as tablets, capsules, and oral liquids, catering to both domestic and international markets. Parmax Pharma operates manufacturing facilities that adhere to Good Manufacturing Practice (GMP) standards to ensure the safety and efficacy of its products. The company is publicly traded on the Bombay Stock Exchange and continues to expand its reach through strategic exports and distribution networks.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Parmax Pharma.